hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges

Dunja Lukovic1,2, Victoria Moreno-Manzano3, Francisco Javier Rodriguez-Jimenez1

  • 11 Stem Cells Therapies in Neurodegenerative Diseases Lab, Research Center "Principe Felipe," Valencia, Spain.

Insights

Human-induced pluripotent stem cells (hiPSC) offer a powerful way to study cerebellar ataxias. These patient-specific cells help researchers understand disease mechanisms and develop treatments.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Cerebellar ataxias are complex genetic disorders affecting the cerebellum.
  • Limited patient tissue hinders research into disease mechanisms.
  • Human-induced pluripotent stem cells (hiPSC) provide a renewable source of patient-specific cells.

Purpose of the Study:

  • To review the application of hiPSC technology in studying cerebellar ataxias.
  • To evaluate the utility of 2D and 3D hiPSC-based models for disease research.
  • To assess the fidelity of extracerebellar cell models in representing cerebellar ataxia.

Main Methods:

  • Review of existing literature on hiPSC use in cerebellar ataxia research.
  • Analysis of 2D and 3D cellular models derived from hiPSCs.
  • Discussion on the use of extracerebellar cells for disease modeling.

Main Results:

  • hiPSC technology enables the generation of large quantities of patient-specific cells for research.
  • 2D and 3D hiPSC models are being developed to study cerebellar ataxias.
  • The use of extracerebellar cells as models for cerebellar diseases is critically examined.

Conclusions:

  • hiPSC technology is a revolutionary tool for investigating cerebellar ataxias.
  • Patient-derived hiPSC models offer new avenues for understanding disease pathogenesis.
  • Further research is needed to validate the accuracy of hiPSC-based models in representing cerebellar ataxia.

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...